EUVIMEDEUVIMED entdecken
Crossref

Next-generation anti-obesity drugs: emerging molecular targets and translational opportunities

Sneha Shetty, Asmi Rangle, Anirban Goutam Mukherjee, Ankit Kumar Bharti, Sudip Prasad Jena, Sabina Evan Prince, Abilash Valsala Gopalakrishnan

Journal of Diabetes & Metabolic Disorders · 19.11.2026 · 26 (1)

DOI: 10.1007/s40200-026-02101-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes & Metabolic Disorders, online erschienen am 19.11.2026. Verfasst von Sneha Shetty und 6 weiteren Autor:innen. Die Arbeit nennt 235 Literaturangaben. Gefördert von: VIT University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • VIT University

Zitieren

APA

Shetty, S., Rangle, A., Mukherjee, A. G., Bharti, A. K., Jena, S. P., Prince, S. E., & Gopalakrishnan, A. V. (2026). Next-generation anti-obesity drugs: emerging molecular targets and translational opportunities. Journal of Diabetes & Metabolic Disorders, 26(1). https://doi.org/10.1007/s40200-026-02101-4

Vancouver

Shetty S, Rangle A, Mukherjee AG, Bharti AK, Jena SP, Prince SE, et al. Next-generation anti-obesity drugs: emerging molecular targets and translational opportunities. Journal of Diabetes & Metabolic Disorders. 2026;26(1). doi:10.1007/s40200-026-02101-4

BibTeX
@article{Shetty2026,
  author = {Shetty, Sneha and Rangle, Asmi and Mukherjee, Anirban Goutam and Bharti, Ankit Kumar and Jena, Sudip Prasad and Prince, Sabina Evan and Gopalakrishnan, Abilash Valsala},
  title = {Next-generation anti-obesity drugs: emerging molecular targets and translational opportunities},
  journal = {Journal of Diabetes & Metabolic Disorders},
  year = {2026},
  volume = {26},
  number = {1},
  doi = {10.1007/s40200-026-02101-4}
}
Kostenlos starten →